0

    541096

    BPLPHARMA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Bharat Parenterals Limited Share Price Today

    Investment Returns

    Over 1 Month 2.76% Over 3 Months 53.56% Over 6 Months 14.53% Over 1 Year 18.42%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Bharat Parenterals Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 964.90
    • P/E Ratio (TTM) 59.49
    • Beta 0.72
    • Book Value / share 583.78
    • Return on equity 8.81%
    • EPS (TTM) 23.24
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 1.38
    info icon alternate text

    Bharat Parenterals Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 56.54
    Operating Expense 59.05
    Net Profit 1.38
    Net Profit Margin (%) 2.44
    Earnings Per Share (EPS) 2.00
    EBITDA 4.48
    Effective Tax Rate (%) 28.49
    Particulars DEC 2025 (Values in Cr)
    Revenue 41.41
    Operating Expense 40.58
    Net Profit 1.92
    Net Profit Margin (%) 4.63
    Earnings Per Share (EPS) 2.78
    EBITDA 5.75
    Effective Tax Rate (%) 38.06
    Particulars SEP 2025 (Values in Cr)
    Revenue 41.70
    Operating Expense 42.49
    Net Profit 2.73
    Net Profit Margin (%) 6.54
    Earnings Per Share (EPS) 3.96
    EBITDA 6.55
    Effective Tax Rate (%) 20.17
    Particulars JUN 2025 (Values in Cr)
    Revenue 94.37
    Operating Expense 82.59
    Net Profit 10.00
    Net Profit Margin (%) 10.59
    Earnings Per Share (EPS) 14.51
    EBITDA 16.88
    Effective Tax Rate (%) 25.37
    Particulars MAR 2025 (Values in Cr)
    Revenue 80.28
    Operating Expense 78.99
    Net Profit 2.28
    Net Profit Margin (%) 2.84
    Earnings Per Share (EPS) 3.48
    EBITDA 6.86
    Effective Tax Rate (%) 35.67
    Particulars MAR 2026 (Values in Cr)
    Revenue 234.01
    Operating Expense 224.73
    Net Profit 16.02
    Net Profit Margin (%) 6.84
    Earnings Per Share (EPS) 23.24
    EBITDA 33.64
    Effective Tax Rate (%) 26.64
    Particulars MAR 2025 (Values in Cr)
    Revenue 304.13
    Operating Expense 282.37
    Net Profit 26.45
    Net Profit Margin (%) 8.69
    Earnings Per Share (EPS) 40.36
    EBITDA 48.16
    Effective Tax Rate (%) 27.14
    Particulars MAR 2024 (Values in Cr)
    Revenue 257.98
    Operating Expense 235.22
    Net Profit 22.59
    Net Profit Margin (%) 8.75
    Earnings Per Share (EPS) 38.97
    EBITDA 41.00
    Effective Tax Rate (%) 26.65
    Particulars MAR 2023 (Values in Cr)
    Revenue 217.98
    Operating Expense 204.65
    Net Profit 24.34
    Net Profit Margin (%) 11.16
    Earnings Per Share (EPS) 42.40
    EBITDA 40.21
    Effective Tax Rate (%) 24.33
    Particulars MAR 2022 (Values in Cr)
    Revenue 212.01
    Operating Expense 191.42
    Net Profit 21.30
    Net Profit Margin (%) 10.04
    Earnings Per Share (EPS) 37.11
    EBITDA 36.00
    Effective Tax Rate (%) 24.92
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 479.79
    ROE % -16.55
    ROCE % -4.76
    Total Debt to Total Equity 0.64
    EBITDA Margin 4.21
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 338.96
    ROE % 5.53
    ROCE % 7.69
    Total Debt to Total Equity 0.55
    EBITDA Margin 12.16
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 316.55
    ROE % 9.01
    ROCE % 12.50
    Total Debt to Total Equity 0.19
    EBITDA Margin 14.69
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 287.16
    ROE % 13.44
    ROCE % 17.10
    Total Debt to Total Equity 0.10
    EBITDA Margin 16.91
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 251.09
    ROE % 15.51
    ROCE % 20.16
    Total Debt to Total Equity 0.05
    EBITDA Margin 16.58
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 561.27
    ROE % 8.81
    ROCE % 10.88
    Total Debt to Total Equity 0.24
    EBITDA Margin 15.84
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 367.05
    ROE % 11.16
    ROCE % 12.94
    Total Debt to Total Equity 0.32
    EBITDA Margin 14.52
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 330.86
    ROE % 11.08
    ROCE % 13.60
    Total Debt to Total Equity 0.17
    EBITDA Margin 13.62
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 287.72
    ROE % 13.74
    ROCE % 17.51
    Total Debt to Total Equity 0.09
    EBITDA Margin 15.08
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 251.22
    ROE % 15.13
    ROCE % 19.72
    Total Debt to Total Equity 0.05
    EBITDA Margin 16.60
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 57.58
    Total Assets 648.53
    Total Liabilities 648.53
    Total Equity 338.99
    Share Outstanding 0
    Price to Book Ratio 1.76
    Return on Assets (%) -1.94
    Return on Capital (%) -2.43
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 14.52
    Total Assets 504.04
    Total Liabilities 504.04
    Total Equity 238.17
    Share Outstanding 0
    Price to Book Ratio 3.06
    Return on Assets (%) 2.88
    Return on Capital (%) 3.67
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 9.98
    Total Assets 350.34
    Total Liabilities 350.34
    Total Equity 217.89
    Share Outstanding 0
    Price to Book Ratio 1.02
    Return on Assets (%) 4.69
    Return on Capital (%) 6.14
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.67
    Total Assets 226.05
    Total Liabilities 226.05
    Total Equity 170.14
    Share Outstanding 0
    Price to Book Ratio 1.19
    Return on Assets (%) 9.31
    Return on Capital (%) 11.21
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 2.43
    Total Assets 198.64
    Total Liabilities 198.64
    Total Equity 143.81
    Share Outstanding 0
    Price to Book Ratio 1.33
    Return on Assets (%) 10.26
    Return on Capital (%) 13.07
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 27.77
    Total Assets 549.19
    Total Liabilities 549.19
    Total Equity 386.82
    Share Outstanding 0
    Price to Book Ratio 1.76
    Return on Assets (%) 4.81
    Return on Capital (%) 5.86
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 5.09
    Total Assets 387.15
    Total Liabilities 387.15
    Total Equity 213.60
    Share Outstanding 0
    Price to Book Ratio 3.06
    Return on Assets (%) 5.83
    Return on Capital (%) 7.62
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 7.42
    Total Assets 308.02
    Total Liabilities 308.02
    Total Equity 191.06
    Share Outstanding 0
    Price to Book Ratio 1.02
    Return on Assets (%) 7.90
    Return on Capital (%) 10.28
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.60
    Total Assets 218.00
    Total Liabilities 218.00
    Total Equity 166.15
    Share Outstanding 0
    Price to Book Ratio 1.19
    Return on Assets (%) 9.77
    Return on Capital (%) 11.76
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 2.15
    Total Assets 196.23
    Total Liabilities 196.23
    Total Equity 143.94
    Share Outstanding 0
    Price to Book Ratio 1.33
    Return on Assets (%) 10.29
    Return on Capital (%) 13.15
    Particulars MAR 2025 (Values in Cr)
    Net Income -33.95
    Cash from Operations -16.65
    Cash from Investing -137.38
    Cash from Financing 156.37
    Net change in Cash -8.26
    Free Cash Flow 12.41
    Particulars MAR 2024 (Values in Cr)
    Net Income 18.72
    Cash from Operations 4.75
    Cash from Investing -104.78
    Cash from Financing 110.42
    Net change in Cash 0.93
    Free Cash Flow 109.05
    Particulars MAR 2023 (Values in Cr)
    Net Income 23.54
    Cash from Operations 30.45
    Cash from Investing -77.81
    Cash from Financing 60.59
    Net change in Cash 4.44
    Free Cash Flow 122.05
    Particulars MAR 2022 (Values in Cr)
    Net Income 27.87
    Cash from Operations 4.60
    Cash from Investing -6.63
    Cash from Financing 9.42
    Net change in Cash 1.72
    Free Cash Flow 43.55
    Particulars MAR 2021 (Values in Cr)
    Net Income 27.12
    Cash from Operations 31.12
    Cash from Investing -43.37
    Cash from Financing 10.49
    Net change in Cash -8.42
    Free Cash Flow 31.96
    Particulars MAR 2025 (Values in Cr)
    Net Income 36.31
    Cash from Operations 29.29
    Cash from Investing -89.68
    Cash from Financing 69.25
    Net change in Cash -1.21
    Free Cash Flow 49.61
    Particulars MAR 2024 (Values in Cr)
    Net Income 30.80
    Cash from Operations 9.30
    Cash from Investing -38.19
    Cash from Financing 33.51
    Net change in Cash -4.84
    Free Cash Flow 19.67
    Particulars MAR 2023 (Values in Cr)
    Net Income 32.16
    Cash from Operations -2.77
    Cash from Investing -13.94
    Cash from Financing 28.52
    Net change in Cash 3.01
    Free Cash Flow 2.28
    Particulars MAR 2022 (Values in Cr)
    Net Income 28.36
    Cash from Operations -16.40
    Cash from Investing 21.75
    Cash from Financing 2.24
    Net change in Cash 1.92
    Free Cash Flow -11.64
    Particulars MAR 2021 (Values in Cr)
    Net Income 27.01
    Cash from Operations 36.35
    Cash from Investing -46.27
    Cash from Financing 8.31
    Net change in Cash -8.28
    Free Cash Flow 41.77
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.08 12.84 1.50 238.18 23.12 38.85
    BLISS GVS PHARMA LTD 530.35 43.05 4.71 5624.69 118.35 541.75
    CIPLA LTD 1453.50 30.85 3.41 117420.32 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 356.70 15.73 2.58 1049.80 256.40 399.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.08 21.73 4.00 238.18 23.12 38.85
    AMRUTAJAN HEALTH LTD 539.05 24.16 4.20 1558.43 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8054.15 105.19 23.07 20135.38 7630.00 9850.00
    BLISS GVS PHARMA LTD 530.35 57.21 4.86 5624.69 118.35 541.75

    Bharat Parenterals Limited shareholding pattern

    Holding
    31.65%
    67.17%
    0.1%
    1.06%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Bharat Parenterals Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1400.00 1.26 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 1352.80
    • 26 Days 1322.10
    • 10 Days 1343.10
    • 50 Days 1281.50
    • 12 Days 1340.80
    • 100 Days 1229.90
    • 20 Days 1331.30
    • 200 Days 1221.70
    1362.85 PIVOT
    First Support 1325.70 First Resistance 1419.65 Second Support 1268.90 Second Resistance 1456.80 Third Support 1231.75 Third Resistance 1513.60
    RSI 60.31 ADX 43.65 MACD 18.69 Williams % R -16.67 Commodity Channel Index (CCI) 86.47
    Date 2026-06-29 Week 2403.00 Same Day 5546.00 Month 1716.00
    1 Year 0.73 3 Year 0.61
    Over 1 Month
    2.76% down
    Over 1 Year
    18.42% down
    Over 3 Months
    53.56% down
    Over 3 Years
    54.20% down
    Over 6 Months
    14.53% down
    Over 5 Years
    30.50% down

    Bharat Parenterals Limited Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    19 Sep 2025 1.0 Final 19 Sep 2025 Equity shares
    25 Jun 2024 1.0 Final 25 Jun 2024 Equity shares
    25 Sep 2023 0.75 Final 25 Sep 2023 Equity shares

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Bharat Parenterals Ltd?

    Answer Field

    Bharat Parenterals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1,400.00 as on Jun 30 2026 03:30 PM.

    What is the Market Cap of Bharat Parenterals Ltd Share?

    Answer Field

    The market cap of Bharat Parenterals Ltd for NSE ₹ 0.00 & for BSE ₹ 964.90 as on Jun 30 2026 03:30 PM.

    What is the 52 Week High and Low of Bharat Parenterals Ltd?

    Answer Field

    The 52 Week High and Low of Bharat Parenterals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1,667.20 and ₹ 880.25.

    What is 1 year return for Bharat Parenterals Ltd?

    Answer Field

    The 1 year returns on the stock has been 18.42%.

    What is the P/E Ratio of Bharat Parenterals Ltd Share?

    Answer Field

    As on Jun 30 2026 03:30 PM the price-to-earnings (PE) ratio for Bharat Parenterals Ltd share is 59.49.

    What is the PB ratio of Bharat Parenterals Ltd Share?

    Answer Field

    As on Jun 30 2026 03:30 PM, the price-to-book (PB) ratio for Bharat Parenterals Ltd share is 583.78.

    How to Buy Bharat Parenterals Ltd Share?

    Answer Field

    You can trade in Bharat Parenterals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Bharat Parenterals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Bharat Parenterals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Bharat Parenterals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |